Astellas and Roche Diabetes Care Japan ink partnership agreement to develop and commercialize integrated diabetes self-management solution with BlueStar®

Posted on by

– Accu-Chek® Guide Me glucose meter to be paired with BlueStar® in Japan, which is being jointly developed by Astellas and Welldoc – – Initiation of clinical trial planned for fiscal year 2023 – TOKYO and COLUMBIA, Md., March 28, 2023 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503,…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.